Eris Lifesciences Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Amit Indubhushan Bakshi, was filed 06 Feb 2023.
Eris Lifesciences Limited: what insiders have been doing
Eris Lifesciences Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). The past year has been quiet: not a single insider filing for Eris Lifesciences Limited. The previous disclosure was published on 18 August 2023.
Since 2021, the database holds 6 purchases and 26 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +43.6%Entry ₹632.25 · Close at T+365 ₹907.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Eris Lifesciences Limited Strong Buy (bullish), based on 10 analysts. Average price target: ₹1,632.20.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,000 shares@ ₹795.7469.6% of flowEquity SharesSEBI:62608f139024f5fd96621b07791fc7ca8adc15da
- 11,750 shares@ ₹615.04981.4% of flowEquity SharesSEBI:7d5e4e2f6843e2d40f87b1c447ada5ea002cb5a0Canonical exit: 3 May 2023 (T+90)
- 203,000 shares@ ₹630.0025.0% of flowEquity SharesSEBI:17c33a4c58f8fd1a77cc9c67616b65d0b7bec139Canonical exit: 20 Apr 2023 (T+90)
- 396,262 shares@ ₹663.0051.7% of flowEquity SharesSEBI:f1aa7708af868daaa46cb49dbd633199b13373afCanonical exit: 14 Mar 2023 (T+90)
- 165,000 shares@ ₹660.70221.9% of flowEquity SharesSEBI:011b0d09952a892800e8156640eb0d096d1175fbCanonical exit: 6 Mar 2023 (T+90)
- 3,400 shares@ ₹695.9247100.0% of flowEquity SharesSEBI:6cb84cb81dae757976df1cfef0554722fca32a97
- 4,990 shares@ ₹451.039914.9% of flowEquity SharesSEBI:09f11cbe747419e4007a0a8de5b4968e6417f8c1
- 4,943 shares@ ₹451.039914.8% of flowEquity SharesSEBI:e2dedc089554609110ce2149c7ec29b9795e0a96
- 2,000 shares@ ₹708.909.5% of flowEquity SharesSEBI:551ee794d154ecf34fb3155433e3e2a78426d18d
- 3,000 shares@ ₹713.266714.2% of flowEquity SharesSEBI:49cc0e2047ddc09142f21770fd771716b2bb12f4
- 4,500 shares@ ₹451.0413.4% of flowEquity SharesSEBI:6e631b975ce6fa84b665fb8dca21faa71afdd9ba
- 8,000 shares@ ₹451.0423.0% of flowEquity SharesSEBI:281483c3b96cc0b744dadb278cf0c85b34dcafb8
- 5,542 shares@ ₹451.040133.8% of flowEquity SharesSEBI:eac33e64d4d4cf501b5cddafc3d587a5b261d3d1
- 1,000 shares@ ₹798.955.2% of flowEquity SharesSEBI:9af7b2af1ff0271615b0b648ed6af8481633e752
- 10,249 shares@ ₹819.52991.3% of flowEquity SharesSEBI:1e24ce7934bbfca3513af93bd36fce00ef89c593
- 2,130 shares@ ₹817.63240.3% of flowEquity SharesSEBI:6dbac5daa432aee9d174483ec7a80eb19493328e
- 5,542 shares@ ₹451.039933.3% of flowEquity SharesSEBI:6f97a407c2af0897c35882268aa6225fa268ea10
- 9,975 shares@ ₹451.04100.0% of flowEquity SharesSEBI:503f4087dc8e5d3794862df98b504bfedc1d5ce7
- 2,500 shares@ ₹451.047.1% of flowEquity SharesSEBI:dbe95b9dd9ff1c0e43a92abe82860d4de8a8c57c
- 882 shares@ ₹769.0034.1% of flowEquity SharesSEBI:d3725ff77af1ed1de9c51c88bfe166876fcd7152
- 2,000 shares@ ₹727.500.0010% mcap100.0% of flowEquity SharesSEBI:7b9821e08a4933d62e060b2de0541990665bc037
- 1,750 shares@ ₹748.71310.0009% mcap65.9% of flowEquity SharesSEBI:82a0a4fed8e840497616366981b0d87b4bccceff
- 3,463 shares@ ₹734.52670.0017% mcap100.0% of flowEquity SharesSEBI:218220370e814cc284daaf1558dbc8532220474b
- 34,534 shares@ ₹728.210357.1% of flowEquity SharesSEBI:5e0443bde149a89a8cac31676ea83fad72d6b65cCanonical exit: 18 Nov 2021 (T+90)
- 26,175 shares@ ₹725.423142.9% of flowEquity SharesSEBI:cf254e4dadb6bdda823fdb6b14024e1dc3c9fc44Canonical exit: 14 Nov 2021 (T+90)
25 of 44 declarations
About Eris Lifesciences Limited
Eris Lifesciences Limited is a company focused on the healthcare and pharmaceutical sector, providing a range of pharmaceutical products. It is listed on the XBOM market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
